CG
RXDX

Cutler Group’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Cutler Group’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-30
Closed -$3K – 2181
2023
Q1 		$3K Sell
30
-6,290
-100% -$629K ﹤0.01% 1221
2022
Q4 		$695K Buy
+6,320
New +$695K 0.06% 223
2022
Q1 		– Hold
0
– – – 2789
2021
Q4 		– Hold
0
– – – 2848